Literature DB >> 33357429

CDK8 Fine-Tunes IL-6 Transcriptional Activities by Limiting STAT3 Resident Time at the Gene Loci.

Jonathan Martinez-Fabregas1, Luopin Wang2, Elizabeth Pohler1, Adeline Cozzani3, Stephan Wilmes1, Majid Kazemian4, Suman Mitra5, Ignacio Moraga6.   

Abstract

Cytokines are highly pleiotropic ligands that regulate the immune response. Here, using interleukin-6 (IL-6) as a model system, we perform detailed phosphoproteomic and transcriptomic studies in human CD4+ T helper 1 (Th-1) cells to address the molecular bases defining cytokine functional pleiotropy. We identify CDK8 as a negative regulator of STAT3 transcriptional activities, which interacts with STAT3 upon IL-6 stimulation. Inhibition of CDK8 activity, using specific small molecule inhibitors, reduces the IL-6-induced phosphoproteome by 23% in Th-1 cells, including STAT3 S727 phosphorylation. STAT3 binding to target DNA sites in the genome is increased upon CDK8 inhibition, which results in a concomitant increase in STAT3-mediated transcriptional activity. Importantly, inhibition of CDK8 activity under Th-17 polarizing conditions results in an enhancement of Th-17 differentiation. Our results support a model where CDK8 regulates STAT3 transcriptional processivity by modulation of its gene loci resident time, critically contributing to diversification of IL-6 responses.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33357429      PMCID: PMC7773550          DOI: 10.1016/j.celrep.2020.108545

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  86 in total

Review 1.  mTOR signaling in growth control and disease.

Authors:  Mathieu Laplante; David M Sabatini
Journal:  Cell       Date:  2012-04-13       Impact factor: 41.582

2.  Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation.

Authors:  Z Wen; Z Zhong; J E Darnell
Journal:  Cell       Date:  1995-07-28       Impact factor: 41.582

3.  A family of cytokine-inducible inhibitors of signalling.

Authors:  R Starr; T A Willson; E M Viney; L J Murray; J R Rayner; B J Jenkins; T J Gonda; W S Alexander; D Metcalf; N A Nicola; D J Hilton
Journal:  Nature       Date:  1997-06-26       Impact factor: 49.962

Review 4.  The code and beyond: transcription regulation by the RNA polymerase II carboxy-terminal domain.

Authors:  Kevin M Harlen; L Stirling Churchman
Journal:  Nat Rev Mol Cell Biol       Date:  2017-03-01       Impact factor: 94.444

5.  The cyclin-dependent kinase inhibitor flavopiridol potentiates doxorubicin efficacy in advanced sarcomas: preclinical investigations and results of a phase I dose-escalation clinical trial.

Authors:  Jason J Luke; David R D'Adamo; Mark A Dickson; Mary Louise Keohan; Richard D Carvajal; Robert G Maki; Elisa de Stanchina; Elgilda Musi; Samuel Singer; Gary K Schwartz
Journal:  Clin Cancer Res       Date:  2012-02-28       Impact factor: 12.531

6.  Kinetics of cytokine receptor trafficking determine signaling and functional selectivity.

Authors:  Jonathan Martinez-Fabregas; Stephan Wilmes; Luopin Wang; Majid Kazemian; Suman Mitra; Ignacio Moraga; Maximillian Hafer; Elizabeth Pohler; Juliane Lokau; Christoph Garbers; Adeline Cozzani; Paul K Fyfe; Jacob Piehler
Journal:  Elife       Date:  2019-11-27       Impact factor: 8.140

Review 7.  The pro- and anti-inflammatory properties of the cytokine interleukin-6.

Authors:  Jürgen Scheller; Athena Chalaris; Dirk Schmidt-Arras; Stefan Rose-John
Journal:  Biochim Biophys Acta       Date:  2011-02-04

Review 8.  IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6.

Authors:  Stefan Rose-John
Journal:  Int J Biol Sci       Date:  2012-10-24       Impact factor: 6.580

Review 9.  STAT3-Mediated Metabolic Reprograming in Cellular Transformation and Implications for Drug Resistance.

Authors:  Valeria Poli; Annalisa Camporeale
Journal:  Front Oncol       Date:  2015-06-08       Impact factor: 6.244

10.  Phosphoproteomic Analyses of Interleukin 2 Signaling Reveal Integrated JAK Kinase-Dependent and -Independent Networks in CD8(+) T Cells.

Authors:  Sarah H Ross; Christina Rollings; Karen E Anderson; Phillip T Hawkins; Len R Stephens; Doreen A Cantrell
Journal:  Immunity       Date:  2016-08-23       Impact factor: 31.745

View more
  10 in total

1.  CDK8 maintains stemness and tumorigenicity of glioma stem cells by regulating the c-MYC pathway.

Authors:  Kazuya Fukasawa; Takuya Kadota; Tetsuhiro Horie; Kazuya Tokumura; Ryuichi Terada; Yuka Kitaguchi; Gyujin Park; Shinsuke Ochiai; Sayuki Iwahashi; Yasuka Okayama; Manami Hiraiwa; Takanori Yamada; Takashi Iezaki; Katsuyuki Kaneda; Megumi Yamamoto; Tatsuya Kitao; Hiroaki Shirahase; Masaharu Hazawa; Richard W Wong; Tomoki Todo; Atsushi Hirao; Eiichi Hinoi
Journal:  Oncogene       Date:  2021-03-16       Impact factor: 9.867

Review 2.  The Mediator kinase module: an interface between cell signaling and transcription.

Authors:  Olivia Luyties; Dylan J Taatjes
Journal:  Trends Biochem Sci       Date:  2022-02-19       Impact factor: 13.807

3.  Inhibition of CDK8/19 Mediator kinase potentiates HER2-targeting drugs and bypasses resistance to these agents in vitro and in vivo.

Authors:  Xiaokai Ding; Amanda C Sharko; Martina S J McDermott; Gary P Schools; Alexander Chumanevich; Hao Ji; Jing Li; Li Zhang; Zachary T Mack; Vitali Sikirzhytski; Michael Shtutman; Laura Ivers; Norma O'Donovan; John Crown; Balázs Győrffy; Mengqian Chen; Igor B Roninson; Eugenia V Broude
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-01       Impact factor: 12.779

4.  Identifying cytokine signaling signatures in primary human Th-1 cells by phospho-proteomics analysis.

Authors:  Jonathan Martinez-Fabregas; Elizabeth Pohler; Ignacio Moraga
Journal:  STAR Protoc       Date:  2021-03-31

Review 5.  Lysosomes: multifunctional compartments ruled by a complex regulatory network.

Authors:  Jonathan Martinez-Fabregas; Joaquin Tamargo-Azpilicueta; Irene Diaz-Moreno
Journal:  FEBS Open Bio       Date:  2022-03-08       Impact factor: 2.693

6.  The effect and mechanism of cypermethrin-induced hippocampal neurotoxicity as determined by network pharmacology analysis and experimental validation.

Authors:  Jianan Li; Haoran Bi
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

7.  Functional analysis of the stable phosphoproteome reveals cancer vulnerabilities.

Authors:  Di Xiao; Hani Jieun Kim; Ignatius Pang; Pengyi Yang
Journal:  Bioinformatics       Date:  2022-01-07       Impact factor: 6.937

8.  The role of CDK8 in mesenchymal stem cells in controlling osteoclastogenesis and bone homeostasis.

Authors:  Takanori Yamada; Kazuya Fukasawa; Tetsuhiro Horie; Takuya Kadota; Jiajun Lyu; Kazuya Tokumura; Shinsuke Ochiai; Sayuki Iwahashi; Akane Suzuki; Gyujin Park; Rie Ueda; Megumi Yamamoto; Tatsuya Kitao; Hiroaki Shirahase; Hiroki Ochi; Shingo Sato; Takashi Iezaki; Eiichi Hinoi
Journal:  Stem Cell Reports       Date:  2022-06-30       Impact factor: 7.294

9.  The Cyclin-Dependent Kinase 8 (CDK8) Inhibitor DCA Promotes a Tolerogenic Chemical Immunophenotype in CD4+ T Cells via a Novel CDK8-GATA3-FOXP3 Pathway.

Authors:  Azlann Arnett; Keagan G Moo; Kaitlin J Flynn; Thomas B Sundberg; Liv Johannessen; Alykhan F Shamji; Nathanael S Gray; Thomas Decker; Ye Zheng; Vivian H Gersuk; Ziaur S Rahman; David E Levy; Isabelle J Marié; Peter S Linsley; Ramnik J Xavier; Bernard Khor
Journal:  Mol Cell Biol       Date:  2021-08-24       Impact factor: 4.272

Review 10.  Endosomes as Signaling Platforms for IL-6 Family Cytokine Receptors.

Authors:  Dirk Schmidt-Arras; Stefan Rose-John
Journal:  Front Cell Dev Biol       Date:  2021-06-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.